Opinion-based articles written by experts working across different areas of the European biotechnology industry.
Opinion 24 Mar 2023
PAN-TB regimens to address growing TB drug resistance
By Dr. Charles Wells, head of therapeutics development at Gates Medical Research Institute As nearly one-quarter of the world’s population…